STAT

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

66

66

European Pharmaceutical Review

DECEMBER 9, 2022

The research noted that the oligonucleotide synthesis market in the Asia-Pacific region is expected to develop at the quickest rate during the forecast period. Growing R&D funding and research activity, higher product availability and lower outsourcing costs are likely to drive market growth. Tag Copenhagen A/S (Denmark).

Compounding 86

Compounding 86

Pharmaceutical Technology

MAY 1, 2023

Australian biotechnology company Cartherics has granted licence for CTH-004 , its autologous CAR-T cell product, to Chinese company Shunxi. Cartherics will retain all the development and commercialisation rights for the therapy outside Greater China. In animal models of ovarian cancer, it demonstrated promising results.

52

52

Viseven

MAY 24, 2023

The bottom line: chatGPT is not going to replace HCPs for the time being but its integration is definitely a promising direction of development, for the sake of higher professional efficiency and patient safety.

Customer Service 52

Customer Service Communication 52

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Cerner 111

Cerner 111

pharmaphorum

AUGUST 21, 2022

NMDA antagonist dextromethorphan is an ingredient found in cough syrups, while bupropion is an established antidepressant that was originally developed by GSK and sold as Wellbutrin. In this product, bupropion is designed to increase levels of dextromethorphan in the blood and extend its half-life. Photo by Sydney Sims on Unsplash.

FDA 96

FDA Labelling 96

pharmaphorum

NOVEMBER 24, 2021

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.

FDA 59

FDA 59

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Automation can be such a solution. Reducing capacity issues. Cutting down on safety stock.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

JULY 23, 2019

Focus New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up. The expert panel will consider exclusive research carried out by Tag and pharmaphorum across the US, Europe and Asia-Pacific among senior decision-makers in pharma and FMCG marketing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 11, 2022

A prescription digital therapeutic (DTx) for leukaemia patients developed by Blue Note Therapeutics has been awarded breakthrough device status by the FDA. Breakthrough designations can speed up the development of new therapies, making them available to patients sooner.

FDA 64

FDA Chemotherapy Hospitals 64

pharmaphorum

JANUARY 11, 2021

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. million price tag. The FDA is now due to make a decision on ide-cel as a treatment for multiple myeloma in late March.

FDA 60

FDA 60

Pharmaceutical Technology

MAY 2, 2023

Although a subset of patients derives long-term benefits from IO therapies, a high percentage of patients still fail to respond or develop resistance to IO therapy. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

Immunization 52

Immunization Vaccines 52

ISPE

DECEMBER 1, 2022

In fact, the local government reported an increase of + 8% of production in the first 4 months of 2022 correlated to an increase of + 32% in exports. In my case, the use of smart tags was a good example of a technologically complex implementation and, at the same time, truly innovative as it had never been done before. Micaela Prati.

98

98

pharmaphorum

APRIL 20, 2021

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. Relapsing and remitting forms of MS account for around 85% of all patients at diagnosis, although some go on to develop more progressive forms.

Hospitals 111

Hospitals Documentation 111

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.

Communication 114

Communication Documentation Labelling Vaccines 114

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Communication 87

Communication Insurance Packaging Pharmaceutical Companies 87

European Pharmaceutical Review

AUGUST 24, 2022

In total, there are 14 approved ADCs on the global market, all for oncology indications, and over 140 ADCs currently in clinical development. generation products from fully delivering on their initial promise. Early ADC developments centred on using cytotoxins with the highest potency together with limited linker designs.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies 82

pharmaphorum

NOVEMBER 19, 2020

Because Roche has never applied for Avastin to be used in wet AMD, clinics in the US have had to choose between the peace of mind offered by the regulatory process and Lucentis’ higher price tag, or the unapproved off-label formulation of Avastin at a lower price.

FDA 64

FDA Labelling 64

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Transformative, lifesaving products are available at increasingly high and unsustainable prices.

Insurance 52

Insurance Vaccines 52

Viseven

JUNE 23, 2022

Being able to build a solid and at the same time flexible content production management for omnichannel purposes sounds like a never-ending nightmare full of additional costs and creative hell. The first of the most uncomfortable issues that happen during content production is time planning. Why is it great for commercial purposes?

Communication 52

Communication 52

pharmaphorum

OCTOBER 29, 2021

Rival drug Tecentriq (atezolizumab) – had its accelerated approval in first-line TNBC withdrawn by developer Roche in the US after failing a confirmatory trial, but is in late-stage testing as a treatment for early-stage TNBC. The post Gilead tags Merck for first-line triple negative breast cancer trial appeared first on.

Chemotherapy 52

Chemotherapy FDA 52

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. This includes the first potential approval of a CRISPR-based gene therapy called exa-cel , which is developed by CRISPR Therapeutics and Vertex Pharmaceuticals. We have products that are living therapies.

FDA 59

FDA Immunization 59

pharmaphorum

DECEMBER 2, 2020

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training as a confectioner. It was a success, and set the pattern for the company’s future development. Under his stewardship, Pfizer’s expertise in scientific production methods developed greatly.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Pharmaceutical Technology

APRIL 13, 2023

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Also known as lovo-cel, bluebird bio’s product is a lentiviral gene therapy. The standard of care for the condition includes blood transfusions, hydroxyurea and iron chelation.

FDA 59

FDA 59

Pharmaceutical Technology

FEBRUARY 22, 2023

Developed by Sanofi and Regeneron, Praluent was approved by the FDA in July 2015. Both drugs come with a high price tag. On the opposing side, Sanofi argues that Amgen’s approach not only violates enablement requirements, but also stifles innovation by stopping others from developing new therapeutics, says Falati.

FDA 104

FDA 104

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. The price is right.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. As computing has developed in the past decade, so has the potential to store and use information in the cloud.

Labelling 105

Labelling Data Entry Communication FDA 105

The Social Pharmacist

AUGUST 2, 2022

Visitors who land on your site appear as potential customers who seek a product or service solution to a recurring problem they have. Let’s say someone unfamiliar with your business seeks products and services you sell or provide. The Key Role of Organic Traffic to Your Pharmacy Business. Organic Search Listing.

52

52

The Checkup by Singlecare

JANUARY 25, 2023

1 in 5 treat sunburn with an aloe vera product with a pain reliever, which is not recommended. However, more were familiar with the terms of broad-spectrum and water resistance in sunscreen products. Less than half (46%) know the minimum recommended level of SPF is 30. 69% use sunscreen when outside.

Documentation 52

Documentation Insurance FDA 52

The Checkup by Singlecare

NOVEMBER 2, 2023

GLP-1 drugs were initially developed for controlling blood sugar (glucose) levels in people with Type 2 diabetes. They do so by stimulating the release of insulin, slowing down the emptying of the stomach, and reducing the production of glucose by the liver. The high price tag is a barrier for many people.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. The global pandemic stifled many content production shoots and live content creation. Content developers realise they need to be flexible in their approach. ” Robb DeFilippis.

Communication 89

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 89

The Checkup by Singlecare

MARCH 21, 2023

Some additional formulations of buprenorphine exist, including a transdermal patch in a product called Butrans , as well as an injectable formulation. Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. RELATED: Belbuca side effects 2.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Already a big player in haemophilia treatments, CSL licensed exclusive global rights to Hemgenix from gene therapy developers uniQure back in 2021.

FDA 98

FDA 98

The FDA Law Blog

JUNE 27, 2023

This includes both forging the application of the FDAMA 115 “single study plus confirmatory evidence” standard as well as expanding the use of accelerated approval for products in conditions outside of cancer. We are proud as a firm of this honor and would also like to extend congratulations to all of this year’s Law360 Rising Stars!

FDA 81

FDA 81

PharmaShots

MARCH 9, 2023

Her notable achievements can be attributed to the fact that she has been acclaimed with the Kenneth Rainin Foundation Synergy Award, Robert Wood Johnson Harold Amos Medical Faculty Development Award, Immunology Faculty Mentor of the Year, and Gastroenterology & Hepatology Teaching Award. LinkedIn Total experience: 16 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

pharmaphorum

NOVEMBER 19, 2021

The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. The market potential for any vaccine currently in trials is lower because the only markets really are the developing countries, which can’t pay the same prices.”.

Vaccines 135

Vaccines Communication 135